MB 111
Alternative Names: MB-111Latest Information Update: 23 May 2024
At a glance
- Originator Mammoth Biosciences
- Class Antihyperlipidaemics; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hyperlipoproteinaemia type I; Hypertriglyceridaemia